COVID-19 Vaccine: Bharat Biotech Recruits 23,000 Volunteers For COVAXIN’s Phase III Trials, Aims 26,000
The Hyderabad based Bharat Biotech finally on the 3rd of January got approval for emergency use of COVAXIN, a potential candidate for the Novel Coronavirus infection. In regard to this,…